Gabather AB (publ) (STO:GABA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0374
-0.0008 (-2.09%)
Sep 12, 2025, 4:49 PM CET
-2.09%
Market Cap8.83M
Revenue (ttm)n/a
Net Income (ttm)-4.55M
Shares Out236.20M
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,647,494
Average Volume624,230
Open0.0410
Previous Close0.0382
Day's Range0.0326 - 0.0410
52-Week Range0.0278 - 0.7300
Beta-0.36
RSI38.76
Earnings DateAug 25, 2025

About Gabather AB

Gabather AB (publ), a pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer’s disease. The company develops GT-002 for the treatment of schizophrenia, major depressive disorder, orphan drug, and alzheimer´s disease. It has a collaborative agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatr... [Read more]

Sector Healthcare
Founded 2014
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol GABA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.